+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Adult Stem Cells Market Size, Share & Trend Analysis Report By Type (Autologous Adult Stem Cells, Allogeneic Adult Stem Cells), By Product & Services (Product, Services), By Indication, By Application, By End Use, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990629
Description Jump to:
The global adult stem cells market size was valued at USD 12.35 billion in 2023 and is projected to grow at a CAGR of 11.2% from 2024 to 2030, driven by several key factors. These cells, found in various tissues and organs, hold immense potential for regenerative medicine and therapeutic applications. As research continues to uncover their capabilities, the market is poised for significant expansion in the coming years.Research and development (R&D) efforts in adult stem cell therapies have intensified, propelled by advances in biotechnology and molecular biology.

Scientists are exploring new sources of adult stem cells, optimizing culture techniques, and refining methods for differentiation into specialized cell types. For instance, Boston Children's Hospital has achieved significant milestones in adult stem cell research, including the isolation of lung stem cells from both normal lungs and those affected by lung cancer. These innovations are expanding the scope of potential applications in treating a wide range of diseases and injuries, from cardiovascular disorders to neurological conditions.

One of the most important drivers of the market is the increasing investment in research and development. Pharmaceutical companies, biotechnology firms, and academic institutions are allocating significant resources to explore the therapeutic potential of adult stem cells across various medical applications. For instance, the Department of Biotechnology (DBT) in India is actively supporting initiatives in many areas of stem cell research from 2019 to 2022. These initiatives include fundamental biological insights, translational research projects, and genetics conversion technologies for power and clinical applications. During this period, DBT committed USD 8.80 million to these projects. These investments support preclinical studies, clinical trials, and the development of scalable manufacturing processes.

Advanced technologies such as CRISPR-Cas9 gene editing and induced pluripotent stem cells (iPSCs) are enhancing researchers' ability to manipulate and utilize stem cells effectively. As R&D efforts yield promising results and regulatory frameworks evolve, the market is poised to expand, offering innovative solutions for treating complex diseases and improving patient outcomes globally.

In addition, the increasing prevalence of chronic diseases represents a significant driver of market growth. Conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders are rising due to aging populations and lifestyle factors. As per the February 2024 report released by the CDC, roughly 129 million individuals in the U.S. are impacted by at least one significant chronic illness. Adult stem cells offer potential therapies that can address the underlying causes of these diseases, providing regenerative solutions that traditional treatments often cannot match. As healthcare systems seek more effective and personalized approaches to managing chronic conditions, the demand for adult stem cell therapies is expected to grow, fueling further research, development, and adoption in clinical settings.

Furthermore, regulatory agencies worldwide are establishing guidelines to ensure the safety, efficacy, and ethical use of adult stem cell therapies. Streamlined approval processes and clearer regulatory pathways encourage investment in commercialization and market expansion, facilitating patient access to advanced treatment options.

Global Adult Stem Cells Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, the publisher has segmented the global adult stem cells market report based on type, product & services, indication, application, end use, and region.
  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Autologous Adult Stem Cells
  • Allogeneic Adult Stem Cells
  • Product & Services Outlook (Revenue, USD Billion, 2018 - 2030)
  • Product
  • Kits, Media, & Reagents
  • Cells & cell lines
  • Hematopoietic
  • Mesenchymal
  • Neural
  • Epithelial/Skin
  • Others
  • Services
  • Indication Outlook (Revenue, USD Billion, 2018 - 2030)
  • Bone and Cartilage Repair
  • Cardiovascular Diseases
  • Inflammatory and Immunological Diseases
  • Liver diseases
  • Cancer
  • GvHD
  • Others
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Therapeutics
  • Disease Modeling
  • Drug Development & Discovery
  • Toxicology Studies
  • Biobanking
  • Tissue Engineering
  • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Biopharmaceutical Companies
  • Research Institutes
  • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product & Services
1.2.3. Indication
1.2.4. Application
1.2.5. End Use
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights
Chapter 3. Adult Stem Cells Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Adult stem cells market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Adult Stem Cells Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Adult stem cells market: Type Movement Analysis
4.3. Adult stem cells market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Autologous Adult Stem Cells
4.5.1. Autologous Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Allogeneic Adult Stem Cells
4.6.1. Allogeneic Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Adult Stem Cells Market: Product & Services Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Adult stem cells market: Product & Services Movement Analysis
5.3. Adult stem cells market by Product & Services Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Product
5.5.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Kits, Media, & Reagents
5.5.2.1. Kits, Media, & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Cells & Cell Lines
5.5.3.1. Cells & Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3.2. Hematopoietic
5.5.3.2.1. Hematopoietic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3.3. Mesenchymal
5.5.3.3.1. Mesenchymal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3.4. Neural
5.5.3.4.1. Neural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3.5. Epithelial/Skin
5.5.3.5.1. Epithelial/Skin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3.6. Others
5.5.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Services
5.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Adult Stem Cells Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Adult stem cells market: Indication Movement Analysis
6.3. Adult stem cells market by Indication Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Bone and Cartilage Repair
6.5.1. Bone and Cartilage Repair Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Cardiovascular Diseases
6.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Inflammatory and Immunological Diseases
6.7.1. Inflammatory and Immunological Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Liver Diseases
6.8.1. Liver Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Cancer
6.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. GvHD
6.10.1. GvHD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Adult Stem Cells Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Adult stem cells market: Application Movement Analysis
7.3. Adult stem cells market by Application Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Therapeutics
7.5.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Disease Modeling
7.6.1. Disease Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Drug Development & Discovery
7.7.1. Drug Development & Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Toxicology Studies
7.8.1. Toxicology Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Biobanking
7.9.1. Biobanking Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Tissue Engineering
7.10.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11. Others
7.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Adult Stem Cells Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Adult stem cells market: End Use Movement Analysis
8.3. Adult stem cells market by End Use Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Biopharmaceutical Companies
8.5.1. Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Research Institutes
8.6.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Hospitals & Clinics
8.7.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Adult Stem Cells Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Regional Adult stem cells market movement analysis
9.3. Adult stem cells market: Regional Estimates & Trend Analysis by Type, Product & Services & End-use
9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.5. North America
9.5.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. U.S.
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Canada
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. UK
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. Germany
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. France
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory framework
9.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Italy
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory framework
9.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Spain
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory framework
9.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Denmark
9.6.7.1. Key country dynamics
9.6.7.2. Competitive scenario
9.6.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Sweden
9.6.8.1. Key country dynamics
9.6.8.2. Competitive scenario
9.6.8.3. Regulatory framework
9.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.9. Norway
9.6.9.1. Key country dynamics
9.6.9.2. Competitive scenario
9.6.9.3. Regulatory framework
9.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
9.7.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Japan
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. China
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. India
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. Australia
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. South Korea
9.7.6.1. Key country dynamics
9.7.6.2. Competitive scenario
9.7.6.3. Regulatory framework
9.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.7. Thailand
9.7.7.1. Key country dynamics
9.7.7.2. Competitive scenario
9.7.7.3. Regulatory framework
9.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Brazil
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. South Africa
9.9.2.1. Key country dynamics
9.9.2.2. Competitive scenario
9.9.2.3. Regulatory framework
9.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. Saudi Arabia
9.9.3.1. Key country dynamics
9.9.3.2. Competitive scenario
9.9.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. UAE
9.9.4.1. Key country dynamics
9.9.4.2. Competitive scenario
9.9.4.3. Regulatory framework
9.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.5. Kuwait
9.9.5.1. Key country dynamics
9.9.5.2. Competitive scenario
9.9.5.3. Regulatory framework
9.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Key Company Market Position Analysis, 2023
10.3. Key Company Profiles
10.3.1. Thermo Fisher Scientific, Inc
10.3.1.1. Company overview
10.3.1.2. Financial performance
10.3.1.3. Product benchmarking
10.3.1.4. Strategic initiatives
10.3.2. STEMCELL Technologies
10.3.2.1. Company overview
10.3.2.2. Financial performance
10.3.2.3. Product benchmarking
10.3.2.4. Strategic initiatives
10.3.3. Osiris Therapeutics
10.3.3.1. Company overview
10.3.3.2. Financial performance
10.3.3.3. Product benchmarking
10.3.3.4. Strategic initiatives
10.3.4. ZenBio, Inc.
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Stempeutics Research
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Fate Therapeutics, Inc.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. BrainStorm Cell Therapeutics Inc.
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Celgene Corporation
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Stemedica Cell Technologies, Inc.
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Vericel Corporation
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 4. Global adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 5. Global adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 6. Global adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 7. Global adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 8. North America adult stem cells market, by region, 2018 - 2030 (USD Million)
Table 9. North America adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 10. North America adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 11. North America adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 12. North America adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 13. North America adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 14. U.S. adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 15. U.S. adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 16. U.S. adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 17. U.S. adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 18. U.S. adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 19. Canada adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 20. Canada adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 21. Canada adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 22. Canada adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 23. Canada adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 24. Mexico adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 25. Mexico adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 26. Mexico adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 27. Mexico adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 28. Mexico adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 29. Europe adult stem cells market, by country, 2018 - 2030 (USD Million)
Table 30. Europe adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 31. Europe adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 32. Europe adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 33. Europe adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 34. Europe adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 35. UK adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 36. UK adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 37. UK adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 38. UK adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 39. UK adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 40. Germany adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 41. Germany adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 42. Germany adult stem cells market, by indication 2018 - 2030 (USD Million)
Table 43. Germany adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 44. Germany adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 45. France adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 46. France adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 47. France adult stem cells market, by indication 2018 - 2030 (USD Million)
Table 48. France adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 49. France adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 50. Italy adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 51. Italy adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 52. Italy adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 53. Italy adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 54. Italy adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 55. Spain adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 56. Spain adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 57. Spain adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 58. Spain adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 59. Spain adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 60. Denmark adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 61. Denmark adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 62. Denmark adult stem cells market, by indication 2018 - 2030 (USD Million)
Table 63. Denmark adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 64. Denmark adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 65. Norway adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 66. Norway adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 67. Norway adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 68. Norway adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 69. Norway adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 70. Sweden adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 71. Sweden adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 72. Sweden adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 73. Sweden adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 74. Sweden adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 75. Asia Pacific adult stem cells market, by country, 2018 - 2030 (USD Million)
Table 76. Asia Pacific adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 77. Asia Pacific adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 78. Asia Pacific adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 79. Asia Pacific adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 80. Asia Pacific adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 81. Japan adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 82. Japan adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 83. Japan adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 84. Japan adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 85. Japan adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 86. China adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 87. China adult stem cells market, by product & services 2018 - 2030 (USD Million)
Table 88. China adult stem cells market, by indication 2018 - 2030 (USD Million)
Table 89. China adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 90. China adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 91. India adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 92. India adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 93. India adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 94. India adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 95. India adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 96. Australia adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 97. Australia adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 98. Australia adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 99. Australia adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 100. Australia adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 101. South Korea adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 102. South Korea adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 103. South Korea adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 104. South Korea adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 105. South Korea adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 106. Thailand adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 107. Thailand adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 108. Thailand adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 109. Thailand adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 110. Thailand adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 111. Latin America adult stem cells market, by country, 2018 - 2030 (USD Million)
Table 112. Latin America adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 113. Latin America adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 114. Latin America adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 115. Latin America adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 116. Latin America adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 117. Brazil adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 118. Brazil adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 119. Brazil adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 120. Brazil adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 121. Brazil adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 122. Argentina adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 123. Argentina adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 124. Argentina adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 125. Argentina adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 126. Argentina adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 127. Middle East & Africa adult stem cells market, by country, 2018 - 2030 (USD Million)
Table 128. Middle East & Africa adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 129. Middle East & Africa adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 130. Middle East & Africa adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 131. Middle East & Africa adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 132. Middle East & Africa adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 133. South Africa adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 134. South Africa adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 135. South Africa adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 136. South Africa adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 137. South Africa adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 138. Saudi Arabia adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 139. Saudi Arabia adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 140. Saudi Arabia adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 141. Saudi Arabia adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 142. Saudi Arabia adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 143. UAE adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 144. UAE adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 145. UAE adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 146. UAE adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 147. UAE adult stem cells market, by end use, 2018 - 2030 (USD Million)
Table 148. Kuwait adult stem cells market, by type, 2018 - 2030 (USD Million)
Table 149. Kuwait adult stem cells market, by product & services, 2018 - 2030 (USD Million)
Table 150. Kuwait adult stem cells market, by indication, 2018 - 2030 (USD Million)
Table 151. Kuwait adult stem cells market, by application, 2018 - 2030 (USD Million)
Table 152. Kuwait adult stem cells market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig 1. Adult stem cells market segmentation
Fig 2. Data analysis models
Fig 3. Market formulation and validation
Fig 4. Data validating & publishing
Fig 5. Market research process
Fig 6. Information procurement
Fig 7. Primary research
Fig 8. Value-chain-based sizing & forecasting
Fig 9. QFD modelling for market share assessment
Fig 10. Market formulation & validation
Fig 11. Commodity flow analysis
Fig 12. Market outlook
Fig 13. Segment snapshot-1
Fig 14. Segment snapshot-2
Fig 15. Competitive landscape snapshot
Fig 16. Market trends & outlook
Fig 17. Porter’s five force analysis
Fig 18. PESTEL analysis
Fig 19. Adult stem cells market, type outlook key takeaways (USD Million)
Fig 20. Adult stem cells market: type movement analysis (USD Million), 2023 & 2030
Fig 21. Autologous adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 22. Allogeneic adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 23. Adult stem cells market, product & services outlook key takeaways (USD Million)
Fig 24. Adult stem cells market: product & services movement analysis (USD Million), 2023 & 2030
Fig 25. Product market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 26. Kits, media, & reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 27. Cells & cell lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 28. Hematopoietic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 29. Mesenchymal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 30. Neural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 31. Epithelial/Skin market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 32. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 33. Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 34. Adult stem cells market, indication outlook key takeaways (USD Million)
Fig 35. Adult stem cells market: indication movement analysis (USD Million), 2023 & 2030
Fig 36. Bone and cartilage repair market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 37. Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 38. Inflammatory and immunological diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 39. Liver diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 40. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 41. GvHD market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 42. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 43. Adult stem cells market, application outlook key takeaways (USD Million)
Fig 44. Adult stem cells market: application movement analysis (USD Million), 2023 & 2030
Fig 45. Therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 46. Disease modeling market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 47. Drug development & discovery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 48. Toxicology studies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 49. Biobanking market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 50. Tissue engineering market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 51. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 52. Adult stem cells market, end use outlook key takeaways (USD Million)
Fig 53. Adult stem cells market: end use movement analysis (USD Million), 2023 & 2030
Fig 54. Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 55. Research institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 56. Biopharmaceutical companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 57. Adult stem cells market: regional key takeaways (USD Million)
Fig 58. Adult stem cells market: regional outlook, 2023 & 2030, USD billion
Fig 59. North America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 60. U.S. adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 61. Canada adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 62. Mexico adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 63. Europe adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 64. UK adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 65. Germany adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 66. France adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 67. Spain adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 68. Italy adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 69. Norway adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 70. Denmark adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 71. Sweden adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 72. Asia Pacific adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 73. China adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 74. Japan adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 75. India adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 76. South Korea adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 77. Australia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 78. Thailand adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 79. Latin America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 80. Brazil adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 81. Argentina adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 82. Middle East and Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 83. South Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 84. Saudi Arabia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 85. UAE adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 86. Kuwait adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 87. List of key emerging company’s/technology disruptors/innovators

Companies Mentioned

  • Thermo Fisher Scientific, Inc
  • STEMCELL Technologies
  • Osiris Therapeutics
  • ZenBio, Inc.
  • Stempeutics Research
  • Fate Therapeutics, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Stemedica Cell Technologies, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 12.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.1 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Middle East Stem Cell Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application, Technology, Therapy, End-use, Country, and Segment Forecasts, 2024-2030 - Product Image

Middle East Stem Cell Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application, Technology, Therapy, End-use, Country, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • Middle East
From
Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030 - Product Image

Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Cancer Stem Cells Market by Type, Source, Cancer Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Cancer Stem Cells Market by Type, Source, Cancer Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Organoids Services Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Application, Source and Geography - Product Image

Organoids Services Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Application, Source and Geography

  • Report
  • 168 Pages
  • Global
From

About the Adult Stem Cell Market

The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders. The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments. Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.